Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Pharmexa seeks approval in Europe for phase II HER-2 DNA AutoVac trial

April 10, 2003

HYB-2055 enters the clinic

April 7, 2003

New patent broadens protection for Virulizin

April 7, 2003

Oxford BioMedica cleared to begin phase II trial of TroVax in colorectal cancer

April 3, 2003

Initiation of first of two expanded phase II trials of GVAX lung cancer vaccine

April 3, 2003

Pharmexa applies to begin phase I trial of HER-2 Protein AutoVac product

April 2, 2003

MediGene discontinues development of CVLP tumor vaccine

March 28, 2003

Protein Design Labs licenses SMART M195 antibody to Actinium

March 20, 2003

H3 Pharma licenses SC-1 from OncoMab

March 19, 2003

WX-G250 + low-dose IL-2 safe and active in progressive, metastatic RCC

March 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...